Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No 'bird brains'? Crows exhibit advanced relational thinking, study suggests

  • In one aspect of vision, computers catch up to primate brain

  • A clear, molecular view of how human color vision evolved

  • A Facebook application knows if you are having a bad day and tells your teacher

  • Personalized advertising attracts more attention and makes contents of ads easier to remember

  • Lost memories might be able to be restored, suggests research into marine snail

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  •